Eurofarma Biosimilars Deal Broadens Access To Latin America For Henlius

Chinese Firm’s Bevacizumab, Rituximab And Trastuzumab Included In $50m Deal

Latin America globe from space
Henlius will broaden access to markets in Latin America through the alliance with Brazil’s Eurofarma • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business